Browse by Subject PD-L1

Showing results 1 to 7 of 7

1
Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens

Yim, Soorin; Hwang, Woochang; Han, Namshik; Lee, Doheon, FRONTIERS IN IMMUNOLOGY, v.13, 2022-05

2
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1

Kim, Kyung Hwan; Pyo, Hongryull; Lee, Hoyoung; Oh, Dongryul; Noh, Jae Myoung; Ahn, Yong Chan; Yoon, Hong In; et al, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, v.113, no.2, pp.415 - 425, 2022-06

3
EP400NL is involved in PD-L1 gene activation by forming a transcriptional coactivator complex

Li, Zidong; Kim, Hyoungmin; Kim, Jaehoon; Park, Jeong Hyeon, BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, v.1866, no.1, 2023-03

4
Longitudinal Intravital Imaging of Tumor-Infiltrating Lymphocyte Motility in Breast Cancer Models

Park, Inwon; Hong, Sujung; Seok, Joon; Lucia, Stephani Edwina; Song, Eunjoo; Kim, Mingyo; Kong, Eunji; et al, JOURNAL OF BREAST CANCER, v.24, no.5, pp.463 - 473, 2021-10

5
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy

Cho, Yeona; Kim, Yejin; Chamseddine, Ibrahim; Lee, Won Hee; Kim, Hye Ryun; Lee, Ik Jae; Hong, Min Hee; et al, RADIOTHERAPY AND ONCOLOGY, v.168, pp.1 - 7, 2022-03

6
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression

Gurung, Smriti; Khan, Fatima; Gunassekaran, Gowri Rangaswamy; Do Yoo, Jae; Vadevoo, Sri Murugan Poongkavithai; Permpoon, Uttapol; Kim, Sang-Hyun; et al, BIOMATERIALS, v.247, 2020-07

7
(The) role of programmed cell death ligand 1 in the regulation of psoriatic inflammation = 건선에서 PD-L1의 염증조절 역할link

Kim, Jong Hoon; 김종훈; Shin, Eui-Cheol; 신의철; et al, 한국과학기술원, 2016

rss_1.0 rss_2.0 atom_1.0